Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-Line”

4,678 trials

Showing 20 of 4,678 results

Not applicableStudy completedNCT04316520
What this trial is testing

Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cancer
University Hospital, Angers 20
Testing effectiveness (Phase 2)Study completedNCT00881751
What this trial is testing

Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer

Who this might be right for
Liver Cancer
Medical University of South Carolina 95
Not applicableStudy completedNCT06518213
What this trial is testing

Efficacy and Safety of First-line ART With BIC/FTC/TAF Introduced at the First Clinical Visit

Who this might be right for
HIV Infections
University Hospital for Infectious Diseases, Croatia 112
Testing effectiveness (Phase 2)Study completedNCT00196820
What this trial is testing

Mono Efficacy of Capecitabine (MoniCa)

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 200
Large-scale testing (Phase 3)Study completedNCT03976323
What this trial is testing

Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)

Who this might be right for
Carcinoma, Nonsquamous Non-small-cell Lung
Merck Sharp & Dohme LLC 1,003
Not applicableLooking for participantsNCT05317494
What this trial is testing

Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece

Who this might be right for
Acute Myeloid Leukemia
AbbVie 100
Large-scale testing (Phase 3)Study completedNCT03745170
What this trial is testing

Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
Innovent Biologics (Suzhou) Co. Ltd. 650
Early research (Phase 1)UnknownNCT05826483
What this trial is testing

Almonertinib in the First-line Treatment of Patients of NSCLC With Poor Performance Status

Who this might be right for
Malignant Tumor of LungPoor Performance Status
Guangzhou Institute of Respiratory Disease 20
Not applicableUnknownNCT04391283
What this trial is testing

First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting

Who this might be right for
Carcinoma, Non-Small-Cell Lung
First Affiliated Hospital of Zhejiang University 500
Not applicableStudy completedNCT01399190
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 68
Testing effectiveness (Phase 2)Looking for participantsNCT06046313
What this trial is testing

Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
First Affiliated Hospital of Zhejiang University 120
Not applicableLooking for participantsNCT06619288
What this trial is testing

Good-first: B/F/TAF As First-line ART

Who this might be right for
HIV Infection
Affiliated Hospital of Nantong University 630
Testing effectiveness (Phase 2)Ended earlyNCT00977561
What this trial is testing

Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Pfizer 9
Testing effectiveness (Phase 2)Study completedNCT01474642
What this trial is testing

Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Advanced or Recurrent Esophageal Squamous Cell Carcinoma
Samsung Medical Center 64
Testing effectiveness (Phase 2)Ended earlyNCT06478862
What this trial is testing

Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy

Who this might be right for
Cancer of OvaryPancreatic Ductal Adenocarcinoma
Lipomedix Pharmaceuticals Inc. 19
Not applicableUnknownNCT04432402
What this trial is testing

Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 124
Testing effectiveness (Phase 2)UnknownNCT02790580
What this trial is testing

Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer Patients

Who this might be right for
Breast Cancer
National University Hospital, Singapore 98
Large-scale testing (Phase 3)Study completedNCT00261703
What this trial is testing

Docetaxel in Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Sanofi 439
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04910386
What this trial is testing

Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers

Who this might be right for
Biliary Tract Neoplasms
3D Medicines (Sichuan) Co., Ltd. 126
Testing effectiveness (Phase 2)Study completedNCT04433156
What this trial is testing

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
Henan Cancer Hospital 26
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation